Vancouver, British Columbia, Mar _19__, 2019 — CannaOne Technologies (CNNA: CSE/FSE: 3CT) (“CannaOne” or the “Company”) wishes to announce that it has entered into a formal agreement with Manna Health Services SA de CV of Mexico City (“Manna”), to undertake the development, launch and operation of an industry leading online CBD product purchase and delivery marketplace for the Country of Mexico. The agreement was signed on March 5, 2019, with a contract term of 36 months and an option to renew for an additional 60 months at the conclusion of the initial period.
CannaOne CEO Solomon Riby-Williams stated, “We’re extremely excited today to be working with Manna Health. CannaOne will exclusively build, manage and oversee a customized enterprise version of BloomKit for Manna Health intended to be the “go-to” online CBD product marketplace in Mexico”.
“BloomKit, our enterprise software solution, will give Manna the capability to offer a flagship and fully operational online CBD marketplace once Mexican regulations are finalized. For example, It will offer Manna the ability to inherently monitor and track pick-up and delivery logistics, and the capability to deliver historical and current trending analytics to ensure optimal management of all CBD sales channels. It will provide this all with the benefit of a simple and easy to use built in eCommerce solution.”
Riby-Williams further added, “This collaboration with Manna will provide CannaOne the immediate credibility of working directly with a highly respected Mexican organization that already has existing partnerships covering retail and commercial land, pharmacies, shopping malls, and tourist destinations throughout Mexico.
Currently, Manna Health is approved by the Mexican government to buy, sell, lease, distribute, import, or export any products related to health and wellness. Once this CBD marketplace has launched, Manna has further committed to CannaOne to jointly study, analyze and utilize all market and consumer data that is collected and retained through the marketplace.”
The Mexico CBD Market:
In latter November 2018, Mexico announced approval for the importation and sale of cannabis products in pharmacies and retailers across the country to service the Mexican population of 130+ million. Sixty product licenses have been initially approved by the COFEPRIS thus far, and it is expected this decision will make cannabis products like hemp-derived CBD available on the shelves of general retailers across the nation.
About Manna Health Services SA de CV
Manna is a Mexico City based company mainly engaged in the business of distributing and supplying health and wellness products for the Mexican mass market. Manna has a large partnership distribution network of both retail outlets and pharmacies across the country. Manna is involved in the rollout of full-scale cannabis legalization in Mexico and it is itself actively pursuing multiple licenses for all marijuana and CBD market sectors expected to be approved in the country.
About CannaOne Technologies
CannaOne has developed Bloomkit, the first product in the Bloom Product Suite; a turnkey enterprise software solution that can be utilized by any B-to-C cannabis company. Inherent functionalities ensure its users the highest levels of on-going customer satisfaction while the adaptability of Bloomkit, gives clients the ability to operate and satisfy regulatory environments of any governing body around the World, truly affording CannaOne the opportunity to serve an overall base of global clientele with a software suite that sits at the forefront of the industry. The Bloom Product Suite™ is representative of complete data driven and design focused software solutions that contain diverse system architectures and provide intelligent, machine learning that will give clients detailed industry business insights and ultimately lead to the creation and management of predictive content and product recommendation engines.
For further information, please contact:
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, “will be”, or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements are based on the Company’s estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of CannaOne to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including capital expenditures and other costs. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. CannaOne will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S.A. NEWSWIRES